Zhejiang Huahai Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Zhejiang Huahai Pharmaceutical Co Ltd cash flow-to-debt ratio. Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥282.81 Million could theoretically repay 0% of its total liabilities (CN¥11.55 Billion) in one year. Check Zhejiang Huahai Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Zhejiang Huahai Pharmaceutical Co Ltd (2001–2025)
Cash flow-to-debt ratio of Zhejiang Huahai Pharmaceutical Co Ltd from 2001 to 2025. Historical debt coverage capacity for Zhejiang Huahai Pharmaceutical Co Ltd across 25 annual periods. Check Zhejiang Huahai Pharmaceutical Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Zhejiang Huahai Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2001–2025)
Zhejiang Huahai Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2001 to 2025. Year-by-year debt coverage analysis for Zhejiang Huahai Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 600521 cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | CN¥1.23 Billion | CN¥12.05 Billion | ▼ -47.2% |
| 2024 | 0.19x | CN¥2.17 Billion | CN¥11.24 Billion | ▼ -9.8% |
| 2023 | 0.21x | CN¥2.22 Billion | CN¥10.35 Billion | ▲ +79.4% |
| 2022 | 0.12x | CN¥1.24 Billion | CN¥10.41 Billion | ▲ +10.6% |
| 2021 | 0.11x | CN¥938.43 Million | CN¥8.69 Billion | ▼ -56.5% |
| 2020 | 0.25x | CN¥1.56 Billion | CN¥6.27 Billion | ▼ -29.9% |
| 2019 | 0.35x | CN¥1.75 Billion | CN¥4.95 Billion | ▲ +3114.7% |
| 2018 | 0.01x | CN¥67.90 Million | CN¥6.16 Billion | ▼ -93.5% |
| 2017 | 0.17x | CN¥546.24 Million | CN¥3.21 Billion | ▼ -15.6% |
| 2016 | 0.20x | CN¥433.10 Million | CN¥2.15 Billion | ▲ +85.3% |
| 2015 | 0.11x | CN¥195.31 Million | CN¥1.80 Billion | ▼ -58.8% |
| 2014 | 0.26x | CN¥328.61 Million | CN¥1.24 Billion | ▼ -22.0% |
| 2013 | 0.34x | CN¥490.29 Million | CN¥1.45 Billion | ▲ +76.2% |
| 2012 | 0.19x | CN¥243.83 Million | CN¥1.27 Billion | ▲ +2.0% |
| 2011 | 0.19x | CN¥197.51 Million | CN¥1.05 Billion | ▼ -53.7% |
| 2010 | 0.41x | CN¥299.47 Million | CN¥735.92 Million | ▼ -33.0% |
| 2009 | 0.61x | CN¥317.44 Million | CN¥522.98 Million | ▲ +198.8% |
| 2008 | 0.20x | CN¥84.20 Million | CN¥414.51 Million | ▼ -57.2% |
| 2007 | 0.47x | CN¥136.52 Million | CN¥287.78 Million | ▲ +36.2% |
| 2006 | 0.35x | CN¥77.54 Million | CN¥222.66 Million | ▲ +12.8% |
| 2005 | 0.31x | CN¥53.30 Million | CN¥172.70 Million | ▼ -79.3% |
| 2004 | 1.49x | CN¥163.73 Million | CN¥110.03 Million | ▲ +180.2% |
| 2003 | 0.53x | CN¥47.41 Million | CN¥89.27 Million | ▲ +18.2% |
| 2002 | 0.45x | CN¥75.34 Million | CN¥167.62 Million | ▲ +81.8% |
| 2001 | 0.25x | CN¥37.51 Million | CN¥151.72 Million | — |